Tag: biopharma nl

Crystalys Therapeutics does not yet have data from pivotal testing of its gout drug, but the company is already considering ...

Drug research continues to produce new advances, some of which are potential cures. But even though more than $800 billion ...

This sounds like something from a dystopian novel, but it's true. People can now bet on clinical trial results and ...

Anthropic deploys Claude Science, an AI workshop for pharmaceutical researchers. The bustling AI startup says this new product goes beyond ...

A Viridian Therapeutics drug for thyroid eye disease now has FDA approvalmaking it just the second treatment for this inflammatory ...

Regulatory pressure mounts on Amgen's inflammatory disorder drug Tavneos at the European Medicines Agency (EMA) recommend revocation of product approval ...

The FDA has expanded approval of a targeted therapy from Gilead Sciences as a new first-line treatment for triple-negative breast ...

After a few gloomy years, biotech IPOs rebound in 2026. A new record for the sector most cash raised by ...

The FDA's operational structure around centers, each governing a particular regulatory or scientific area, dates back more than 40 years. ...

Servier is expanding its neurology focus to include neuromuscular disorders by acquiring a clinical-stage Edgewise Therapeutics drug that offers a ...